OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PDGF in organ fibrosis
Barbara M. Klinkhammer, Jürgen Floege, Peter Boor
Molecular Aspects of Medicine (2017) Vol. 62, pp. 44-62
Closed Access | Times Cited: 170

Showing 1-25 of 170 citing articles:

Shared and distinct mechanisms of fibrosis
Jörg H. W. Distler, Andrea‐Hermina Györfi, Meera Ramanujam, et al.
Nature Reviews Rheumatology (2019) Vol. 15, Iss. 12, pp. 705-730
Closed Access | Times Cited: 460

Cellular and molecular mechanisms of kidney fibrosis
Sonja Djudjaj, Peter Boor
Molecular Aspects of Medicine (2018) Vol. 65, pp. 16-36
Closed Access | Times Cited: 377

Wound healing, fibroblast heterogeneity, and fibrosis
Heather E. Talbott, Shamik Mascharak, Michelle Griffin, et al.
Cell stem cell (2022) Vol. 29, Iss. 8, pp. 1161-1180
Open Access | Times Cited: 348

The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer
M. Ben Hammouda, Amy E. Ford, Yuan Liu, et al.
Cells (2020) Vol. 9, Iss. 4, pp. 857-857
Open Access | Times Cited: 206

Inflammasomes and Fibrosis
Wenjuan Zhang, Shujuan Chen, Shunchang Zhou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 152

The Role of Myofibroblasts in Physiological and Pathological Tissue Repair
Ronen Schuster, Fereshteh S. Younesi, Maya Ezzo, et al.
Cold Spring Harbor Perspectives in Biology (2022) Vol. 15, Iss. 1, pp. a041231-a041231
Open Access | Times Cited: 106

Single-cell analysis identifies the interaction of altered renal tubules with basophils orchestrating kidney fibrosis
Tomohito Doke, Amin Abedini, Daniel L. Aldridge, et al.
Nature Immunology (2022) Vol. 23, Iss. 6, pp. 947-959
Closed Access | Times Cited: 78

Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis
Rikke Nørregaard, Henricus A. M. Mutsaers, Jørgen Frøkiær, et al.
Physiological Reviews (2023) Vol. 103, Iss. 4, pp. 2847-2892
Open Access | Times Cited: 47

Deciphering the functional heterogeneity of skin fibroblasts using single‐cell RNA sequencing
Vera Vorstandlechner, Maria Laggner, Polina Kalinina, et al.
The FASEB Journal (2020) Vol. 34, Iss. 3, pp. 3677-3692
Open Access | Times Cited: 124

HDAC Inhibitors: Therapeutic Potential in Fibrosis-Associated Human Diseases
Somy Yoon, Gaeun Kang, Gwang Hyeon Eom
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1329-1329
Open Access | Times Cited: 90

TGF beta −1, −2 and −3 in the modulation of fibrosis in the cornea and other organs
Steven E. Wilson
Experimental Eye Research (2021) Vol. 207, pp. 108594-108594
Open Access | Times Cited: 85

Temporal control of PDGFRα regulates the fibroblast-to-myofibroblast transition in wound healing
Longbiao Yao, Bharath Rathnakar, Hae Ryong Kwon, et al.
Cell Reports (2022) Vol. 40, Iss. 7, pp. 111192-111192
Open Access | Times Cited: 43

Signaling Pathways and Potential Therapeutic Strategies in Cardiac Fibrosis
Alexandrine Foucault‐Bertaud, Ahmad Joshkon, Xavier Heim, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1756-1756
Open Access | Times Cited: 24

Epigenetics as a versatile regulator of fibrosis
Yang Liu, Dongsheng Wen, Chiakang Ho, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 22

Current status of drugs targeting PDGF/PDGFR
Jing-Yan Ai, Chenfu Liu, Wen Zhang, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 103989-103989
Closed Access | Times Cited: 13

Signaling pathways in liver cancer: pathogenesis and targeted therapy
Yangtao Xue, Yeling Ruan, Yali Wang, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 12

TGF-β and RAS jointly unmask primed enhancers to drive metastasis
Jun Ho Lee, Francisco J. Sánchez‐Rivera, Lan He, et al.
Cell (2024) Vol. 187, Iss. 22, pp. 6182-6199.e29
Closed Access | Times Cited: 11

Therapeutic potential of Angelica sinensis in addressing organ fibrosis: A comprehensive review
Xiaodong Zhi, Chunzhen Ren, Qianrong Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116429-116429
Open Access | Times Cited: 9

Progressive lung fibrosis: reprogramming a genetically vulnerable bronchoalveolar epithelium
James P. Bridges, Eszter K. Vladar, Jonathan S. Kurche, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 1
Closed Access | Times Cited: 1

Dysregulated mesenchymal PDGFR‐β drives kidney fibrosis
Eva Miriam Buhl, Sonja Djudjaj, Barbara M. Klinkhammer, et al.
EMBO Molecular Medicine (2020) Vol. 12, Iss. 3
Open Access | Times Cited: 65

Platelet-derived growth factor receptor-α is essential for cardiac fibroblast survival
Malina J. Ivey, Jill T. Kuwabara, Kara L. Riggsbee, et al.
AJP Heart and Circulatory Physiology (2019) Vol. 317, Iss. 2, pp. H330-H344
Open Access | Times Cited: 61

PDGF-PDGFR network differentially regulates the fate, migration, proliferation, and cell cycle progression of myogenic cells
Osvaldo Contreras, Adriana Córdova-Casanova, Enrique Brandan
Cellular Signalling (2021) Vol. 84, pp. 110036-110036
Open Access | Times Cited: 43

Research progress on drugs targeting the TGF-β signaling pathway in fibrotic diseases
Ning Shi, Zhihong Wang, Hecheng Zhu, et al.
Immunologic Research (2022) Vol. 70, Iss. 3, pp. 276-288
Open Access | Times Cited: 37

New Aspects of Kidney Fibrosis–From Mechanisms of Injury to Modulation of Disease
Marcus J. Moeller, Rafael Kramann, Twan Lammers, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 35

Page 1 - Next Page

Scroll to top